PL340456A1 - Novel oral dosage form of carvedilol - Google Patents

Novel oral dosage form of carvedilol

Info

Publication number: PL340456A1
Authority: PL; Poland
Prior art keywords: carvedilol; dosage form; oral dosage; novel oral; novel
Prior art date: 1997-11-12

Application number

PL98340456A

Other languages

English (en)

Inventor

Choon K Oh

Original Assignee

Boehringer Mannheim Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-12

Filing date

1998-11-12

Publication date

2001-02-12

1998-11-12 Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp

2001-02-12 Publication of PL340456A1 publication Critical patent/PL340456A1/xx

Links

NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title 1
229960004195 carvedilol Drugs 0.000 title 1
239000006186 oral dosage form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)

PL98340456A 1997-11-12 1998-11-12 Novel oral dosage form of carvedilol PL340456A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6545697P	1997-11-12	1997-11-12
PCT/US1998/024102 WO1999024017A1 (fr)	1997-11-12	1998-11-12	Nouvelle forme posologique par voie orale pour le carvedilol

Publications (1)

Publication Number	Publication Date
PL340456A1 true PL340456A1 (en)	2001-02-12

Family

ID=22062830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL98340456A PL340456A1 (en)	1997-11-12	1998-11-12	Novel oral dosage form of carvedilol

Country Status (14)

Country	Link
EP (1)	EP1030651A4 (fr)
JP (1)	JP2001522794A (fr)
KR (1)	KR20010031952A (fr)
CN (1)	CN1285738A (fr)
AU (1)	AU751117B2 (fr)
BR (1)	BR9814127A (fr)
CA (1)	CA2309542A1 (fr)
HU (1)	HUP0004345A3 (fr)
IL (1)	IL136028A0 (fr)
NO (1)	NO20002439D0 (fr)
NZ (1)	NZ504418A (fr)
PL (1)	PL340456A1 (fr)
TR (1)	TR200001362T2 (fr)
WO (1)	WO1999024017A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004041252A1 (fr)	2002-11-08	2004-05-21	Egalet A/S	Compositions de carvedilol a liberation commandee
AU2003288608A1 (en) *	2002-12-20	2004-07-14	Ranbaxy Laboratories Limited	Controlled release, multiple unit drug delivery systems
JP2007512350A (ja) *	2003-11-25	2007-05-17	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	カルベジロール組成物の治療および送達方法
US8734850B2 (en) *	2003-11-25	2014-05-27	Flamel Technologies	Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
CA2648278C (fr) *	2006-04-03	2019-05-28	Isa Odidi	Composition d'administration de medicament
TWI415604B (zh) *	2009-09-29	2013-11-21	Tsh Biopharm Corp Ltd	調控釋放卡菲蒂羅劑型
JP5749247B2 (ja) *	2010-02-22	2015-07-15	第一三共株式会社	経口用徐放性固形製剤
EP2540317A4 (fr) *	2010-02-22	2014-04-16	Daiichi Sankyo Co Ltd	Préparation solide à libération prolongée pour usage oral
ES2600894T3 (es) *	2010-02-22	2017-02-13	Daiichi Sankyo Company, Limited	Preparación sólida de liberación sostenida para uso oral
RU2665372C2 (ru)	2012-09-03	2018-08-29	Дайити Санкио Компани, Лимитед	Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
KR102158339B1 (ko) *	2016-02-05	2020-09-21	삼진제약주식회사	인습성이 개선된 카르베딜롤 속방성 제제
KR102525298B1 (ko)	2020-12-30	2023-04-25	단국대학교 천안캠퍼스 산학협력단	경구 생체이용률이 증가된 주석산을 포함하는 카베디롤 함유 고체분산체 및 이의 제조방법
KR102492147B1 (ko)	2020-12-30	2023-01-26	단국대학교 천안캠퍼스 산학협력단	자가나노유화 약물전달 시스템을 이용한 카베디롤 함유 경구용 고형제제 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (de) *	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS5598120A (en) *	1979-01-16	1980-07-25	Shin Etsu Chem Co Ltd	Preparation of drug having enteric coating
CA1146866A (fr) *	1979-07-05	1983-05-24	Yamanouchi Pharmaceutical Co. Ltd.	Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
US4680323A (en) *	1983-12-01	1987-07-14	Hans Lowey	Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
WO1992006622A1 (fr) *	1990-10-23	1992-04-30	Davband Pty. Limited	Support dorsal pour une chaise ou un siege
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
DE19637082A1 (de) *	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Schnellzerfallende Pellets

1998
- 1998-11-12 PL PL98340456A patent/PL340456A1/xx unknown
- 1998-11-12 EP EP98958546A patent/EP1030651A4/fr not_active Withdrawn
- 1998-11-12 KR KR1020007005059A patent/KR20010031952A/ko not_active Ceased
- 1998-11-12 CN CN98813082A patent/CN1285738A/zh active Pending
- 1998-11-12 AU AU14569/99A patent/AU751117B2/en not_active Ceased
- 1998-11-12 WO PCT/US1998/024102 patent/WO1999024017A1/fr not_active Ceased
- 1998-11-12 IL IL13602898A patent/IL136028A0/xx not_active IP Right Cessation
- 1998-11-12 CA CA002309542A patent/CA2309542A1/fr not_active Abandoned
- 1998-11-12 JP JP2000520110A patent/JP2001522794A/ja active Pending
- 1998-11-12 BR BR9814127-9A patent/BR9814127A/pt not_active IP Right Cessation
- 1998-11-12 HU HU0004345A patent/HUP0004345A3/hu unknown
- 1998-11-12 TR TR2000/01362T patent/TR200001362T2/xx unknown
- 1998-11-12 NZ NZ504418A patent/NZ504418A/xx unknown
2000
- 2000-05-11 NO NO20002439A patent/NO20002439D0/no unknown

Also Published As

Publication number	Publication date
TR200001362T2 (tr)	2000-09-21
HUP0004345A3 (en)	2001-10-29
WO1999024017A1 (fr)	1999-05-20
NO20002439L (no)	2000-05-11
CN1285738A (zh)	2001-02-28
EP1030651A1 (fr)	2000-08-30
AU751117B2 (en)	2002-08-08
NZ504418A (en)	2003-02-28
AU1456999A (en)	1999-05-31
BR9814127A (pt)	2000-10-03
IL136028A0 (en)	2001-05-20
JP2001522794A (ja)	2001-11-20
HUP0004345A2 (hu)	2001-06-28
EP1030651A4 (fr)	2006-05-31
NO20002439D0 (no)	2000-05-11
CA2309542A1 (fr)	1999-05-20
KR20010031952A (ko)	2001-04-16

Publication	Publication Date	Title
IL195339A0 (en)	2009-08-03	Solid oral dosage forms of valsartan
PL341428A1 (en)	2001-04-09	Oral pharmacological dosage form of prolonged release type
HUP9903407A3 (en)	2000-11-28	Oral pharmaceutical preparation containing ibandronat
HUP9603064A2 (en)	1997-08-28	New oral pharmaceutical dosage form
EP1020193A4 (fr)	2006-05-24	Preparation orale
AU7375598A (en)	1998-11-27	Stable oral pharmaceutical dosage forms
HUP0203204A3 (en)	2004-06-28	Oral dosage forms
HUP9901454A3 (en)	2001-04-28	Dosage form of ibuprofen
PL322579A1 (en)	1998-02-02	2-methyl-thiene-benzodiazeoin prparation for oral administration
HUP0003757A3 (en)	2001-07-30	Oral pharmaceutical compositions of levosimendan
HUP0100090A3 (en)	2002-11-28	Oral care composition
PL335502A1 (en)	2000-04-25	Paracetamol containing oral tablet
IL138192A0 (en)	2001-11-25	Controlled release oral dosage forms
PL340456A1 (en)	2001-02-12	Novel oral dosage form of carvedilol
HU9500618D0 (en)	1995-04-28	Oral pharmaceutical compositions
PL352062A1 (en)	2003-07-28	Oral solution of prucalopride
HUP0201667A3 (en)	2003-02-28	Oral form of administration
GB9718616D0 (en)	1997-11-05	Oral vaccine
ZA974125B (en)	1998-11-13	Oral pharmaceutical compositions
SG63838A1 (en)	1999-03-30	Oral composition
GB9930266D0 (en)	2000-02-09	Oral administration of beneficial substances
SI1043976T1 (sl)	2006-04-30	Oralna farmacevtska dozirna oblika s podaljsanim sproscanjem
GB9718683D0 (en)	1997-11-05	Novel dosage form
HUP0101012A3 (en)	2002-12-28	Pharmaceutical composition for oral administration
GB9711046D0 (en)	1997-07-23	Oral pharmaceutical compositions